Covered recipient · General Payments record
GAYLE L KELLER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,523.14
- Reported across 114 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $384.92 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $223.80 | 18 |
| Neurocrine BioSciences, Inc. | $57.89 | 4 |
| Amgen Inc. | $27.55 | 2 |
| Vanda Pharmaceuticals Inc. | $19.44 | 1 |
| Lilly USA, LLC | $14.88 | 1 |
| Otsuka America Pharmaceutical, Inc. | $14.12 | 1 |
| Axsome Therapeutics, Inc. | $14.04 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.52 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447000 | CMS |
| ABBVIE INC. | $8.24 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447002 | CMS |
| ABBVIE INC. | $10.16 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447004 | CMS |
| ABBVIE INC. | $5.96 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447006 | CMS |
| ABBVIE INC. | $11.50 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447008 | CMS |
| ABBVIE INC. | $16.52 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447010 | CMS |
| ABBVIE INC. | $18.56 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447012 | CMS |
| ABBVIE INC. | $15.57 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447014 | CMS |
| ABBVIE INC. | $7.01 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447016 | CMS |
| ABBVIE INC. | $14.97 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447018 | CMS |
| ABBVIE INC. | $14.55 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447020 | CMS |
| ABBVIE INC. | $8.00 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447022 | CMS |
| ABBVIE INC. | $10.78 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447024 | CMS |
| ABBVIE INC. | $10.65 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447026 | CMS |
| ABBVIE INC. | $23.46 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447028 | CMS |
| ABBVIE INC. | $17.02 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447030 | CMS |
| ABBVIE INC. | $8.99 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447032 | CMS |
| ABBVIE INC. | $8.34 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107447034 | CMS |
| Amgen Inc. | $14.43 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115797613 | CMS |
| Amgen Inc. | $13.12 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115797621 | CMS |
| Axsome Therapeutics, Inc. | $14.04 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148360124 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.20 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118037730 | CMS |
| Lilly USA, LLC | $14.88 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135674204 | CMS |
| Neurocrine Biosciences, Inc. | $13.90 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151007959 | CMS |
| Neurocrine Biosciences, Inc. | $13.71 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151008617 | CMS |
| Neurocrine Biosciences, Inc. | $14.22 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151006931 | CMS |
| Neurocrine Biosciences, Inc. | $16.06 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150999582 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.12 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119110133 | CMS |
| Vanda Pharmaceuticals Inc. | $19.44 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133951590 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.